Skip to main content

SATURNA CAPITAL CORP

Position in NVS — Novartis AG

CIK 1316617 BELLINGHAM, WA

Position in NVS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$47,506,472
+$4,399,763 QoQ
Shares Held
311,008
-0.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95.8380491820146.ToString("F0")% Shared 0.ToString("F0")% None 4.16195081798539.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. NVS ranks #5 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVS
Novartis AG
This page
311,008 $47,506,472

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $47,506,472 311,008
2025-12-31 $43,106,709 312,662
2025-09-30 $40,434,200 315,301
2025-06-30 $38,224,154 315,876
2025-03-31 $35,692,105 320,166
2024-12-31 $31,165,084 320,266
2024-09-30 $36,578,430 318,018
2024-06-30 $34,749,927 326,413
2024-03-31 $31,716,219 327,884
2023-12-31 $33,083,426 327,656
2023-09-30 $33,558,897 329,461
2023-06-30 $31,450,216 311,666
2023-03-31 $28,544,472 310,266
2022-12-31 $28,186,341 310,696
2022-09-30 $24,795,602 326,215
2022-06-30 $27,553,229 325,958
2022-03-31 $28,583,509 325,738
2021-12-31 $28,001,596 320,128
2021-09-30 $26,274,114 321,278
2021-06-30 $25,882,324 283,673
2021-03-31 $24,017,572 280,973
2020-12-31 $28,012,942 296,653
2020-09-30 $25,756,943 296,193
2020-06-30 $25,835,434 295,803
2020-03-31 $24,355,977 295,403